{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T13:34:38Z","timestamp":1789220078618,"version":"build-2803163510"},"reference-count":226,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002460","name":"Chung-Ang University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002460","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003669","name":"Korea Centers for Disease Control and Prevention","doi-asserted-by":"publisher","award":["2020R1A2C1010217"],"award-info":[{"award-number":["2020R1A2C1010217"]}],"id":[{"id":"10.13039\/501100003669","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jmmc-online.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular and Cellular Cardiology"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.yjmcc.2025.02.010","type":"journal-article","created":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T11:41:17Z","timestamp":1740570077000},"page":"105-121","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Lipotoxicity as a therapeutic target in the type 2 diabetic heart"],"prefix":"10.1016","volume":"201","author":[{"given":"Trang Van T.","family":"Luong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seonbu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaetaek","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yjmcc.2025.02.010_bb0005","series-title":"International Diabetes Federation","year":"2021"},{"issue":"4","key":"10.1016\/j.yjmcc.2025.02.010_bb0010","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.011295","article-title":"Diabetes mellitus\u2013related all-cause and cardiovascular mortality in a national cohort of adults","volume":"8","author":"Raghavan","year":"2019","journal-title":"J. Am. Heart Assoc."},{"issue":"11","key":"10.1016\/j.yjmcc.2025.02.010_bb0015","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1161\/CIRCRESAHA.120.315913","article-title":"Basic mechanisms of diabetic heart disease","volume":"126","author":"Ritchie","year":"2020","journal-title":"Circ. Res."},{"issue":"4","key":"10.1016\/j.yjmcc.2025.02.010_bb0020","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1097\/EC9.0000000000000024","article-title":"The role of lipotoxicity in cardiovascular disease","volume":"2","author":"Chuanbao","year":"2022","journal-title":"Emerg. Crit. Care Med."},{"issue":"5","key":"10.1016\/j.yjmcc.2025.02.010_bb0025","doi-asserted-by":"crossref","DOI":"10.1152\/ajpendo.00509.2009","article-title":"Shedding light on the enigma of myocardial lipotoxicity: the involvement of known and putative regulators of fatty acid storage and mobilization","volume":"298","author":"Brindley","year":"2010","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.yjmcc.2025.02.010_bb0030","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1093\/cvr\/cvr212","article-title":"Lipotoxicity in type 2 diabetic cardiomyopathy","volume":"92","author":"Van de Weijer","year":"2011","journal-title":"Cardiovasc. Res."},{"issue":"3","key":"10.1016\/j.yjmcc.2025.02.010_bb0035","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1586\/14779072.2014.891939","article-title":"The role of cardiac lipotoxicity in the pathogenesis of diabetic cardiomyopathy","volume":"12","author":"Ussher","year":"2014","journal-title":"Expert Rev. Cardiovasc. Ther."},{"issue":"10","key":"10.1016\/j.yjmcc.2025.02.010_bb0040","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1016\/j.bbalip.2016.02.011","article-title":"Lipotoxicity in obesity and diabetes-related cardiac dysfunction","volume":"1861","author":"Zlobine","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.yjmcc.2025.02.010_bb0045","first-page":"17","article-title":"A comprehensive review of the novel therapeutic targets for the treatment of diabetic cardiomyopathy","author":"Dhar","year":"2023","journal-title":"Ther Adv. Cardiovasc. Dis."},{"key":"10.1016\/j.yjmcc.2025.02.010_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112413","article-title":"Natural and chemical compounds as protective agents against cardiac lipotoxicity","volume":"145","author":"Yarmohammadi","year":"2022","journal-title":"Biomed. Pharmacother."},{"issue":"3","key":"10.1016\/j.yjmcc.2025.02.010_bb0055","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1093\/cvr\/cvab120","article-title":"Concurrent diabetes and heart failure: interplay and novel therapeutic approaches","volume":"118","author":"Karwi","year":"2022","journal-title":"Cardiovasc. Res."},{"issue":"1","key":"10.1016\/j.yjmcc.2025.02.010_bb0060","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s12933-024-02136-y","article-title":"The double burden: type 1 diabetes and heart failure-a comprehensive review","volume":"23","author":"Juli\u00e1n","year":"2024","journal-title":"Cardiovasc. Diabetol."},{"issue":"4","key":"10.1016\/j.yjmcc.2025.02.010_bb0065","doi-asserted-by":"crossref","first-page":"R225","DOI":"10.1530\/JME-16-0249","article-title":"Lipid metabolism and its implications for type 1 diabetes-associated cardiomyopathy","volume":"58","author":"Ritchie","year":"2017","journal-title":"J. Mol. Endocrinol."},{"key":"10.1016\/j.yjmcc.2025.02.010_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.122087","article-title":"Current understanding of structural and molecular changes in diabetic cardiomyopathy","volume":"332","author":"Akhtar","year":"2023","journal-title":"Life Sci."},{"issue":"4","key":"10.1016\/j.yjmcc.2025.02.010_bb0075","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.pcad.2019.03.003","article-title":"Diabetic cardiomyopathy - a comprehensive updated review","volume":"62","author":"Murtaza","year":"2019","journal-title":"Prog. Cardiovasc. Dis."},{"issue":"9","key":"10.1016\/j.yjmcc.2025.02.010_bb0080","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/s41569-020-0339-2","article-title":"Mechanisms of diabetic cardiomyopathy and potential therapeutic strategies: preclinical and clinical evidence","volume":"17","author":"Tan","year":"2020","journal-title":"Nat. Rev. Cardiol."},{"issue":"4","key":"10.1016\/j.yjmcc.2025.02.010_bb0085","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.3390\/biomedicines11041126","article-title":"Exploring the complex relationship between diabetes and cardiovascular complications: understanding diabetic cardiomyopathy and promising therapies","volume":"11","author":"Ghosh","year":"2023","journal-title":"Biomedicines"},{"issue":"3","key":"10.1016\/j.yjmcc.2025.02.010_bb0090","doi-asserted-by":"crossref","first-page":"404","DOI":"10.3904\/kjim.2016.208","article-title":"Diabetic cardiomyopathy: where we are and where we are going","volume":"32","author":"Lee","year":"2017","journal-title":"Korean J. Intern. Med."},{"issue":"1","key":"10.1016\/j.yjmcc.2025.02.010_bb0095","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1093\/eurheartj\/ehp396","article-title":"Abnormal myocardial insulin signalling in type 2 diabetes and left-ventricular dysfunction","volume":"31","author":"Cook","year":"2010","journal-title":"Eur. Heart J."},{"issue":"2","key":"10.1016\/j.yjmcc.2025.02.010_bb0100","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.cardiores.2003.11.021","article-title":"Initial steps of insulin signaling and glucose transport are defective in the type 2 diabetic rat heart","volume":"61","author":"Desrois","year":"2004","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.yjmcc.2025.02.010_bb0105","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ijcard.2016.12.083","article-title":"Glucose transporters in healthy heart and in cardiac disease","volume":"230","author":"Szablewski","year":"2017","journal-title":"Int. J. Cardiol."},{"issue":"3","key":"10.1016\/j.yjmcc.2025.02.010_bb0110","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1677\/jme.0.0310449","article-title":"Threshold effects of glucose transporter-4 (GLUT4) deficiency on cardiac glucose uptake and development of hypertrophy","volume":"31","author":"Kaczmarczyk","year":"2003","journal-title":"J. Mol. Endocrinol."},{"issue":"2","key":"10.1016\/j.yjmcc.2025.02.010_bb0115","doi-asserted-by":"crossref","first-page":"e135","DOI":"10.1016\/j.ddmec.2010.08.001","article-title":"Diabetic cardiomyopathy: mechanisms and therapeutic targets","volume":"7","author":"Battiprolu","year":"2010","journal-title":"Drug Discov. Today Dis. Mech."},{"issue":"2","key":"10.1016\/j.yjmcc.2025.02.010_bb0120","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.bbalip.2005.03.005","article-title":"Fatty acid metabolism is enhanced in type 2 diabetic hearts","volume":"1734","author":"Carley","year":"2005","journal-title":"Biochim. Biophys. Acta"},{"issue":"4","key":"10.1016\/j.yjmcc.2025.02.010_bb0125","doi-asserted-by":"crossref","first-page":"H1489","DOI":"10.1152\/ajpheart.00278.2006","article-title":"Role of changes in cardiac metabolism in development of diabetic cardiomyopathy","volume":"291","author":"An","year":"2006","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"4","key":"10.1016\/j.yjmcc.2025.02.010_bb0130","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.hfc.2012.06.008","article-title":"Myocardial fatty acid metabolism and lipotoxicity in the setting of insulin resistance","volume":"8","author":"Kok","year":"2012","journal-title":"Heart Fail. Clin."},{"issue":"10","key":"10.1016\/j.yjmcc.2025.02.010_bb0135","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/j.bbalip.2016.02.016","article-title":"Lipid metabolism and signaling in cardiac lipotoxicity","volume":"1861","author":"D'Souza","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"issue":"1","key":"10.1016\/j.yjmcc.2025.02.010_bb0140","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1161\/CIRCRESAHA.118.311371","article-title":"Heart failure in type 2 diabetes mellitus","volume":"124","author":"Kenny","year":"2019","journal-title":"Circ. Res."},{"issue":"3","key":"10.1016\/j.yjmcc.2025.02.010_bb0145","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1172\/JCI60329","article-title":"Metabolic stress-induced activation of FOXO1 triggers diabetic cardiomyopathy in mice","volume":"122","author":"Battiprolu","year":"2012","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.yjmcc.2025.02.010_bb0150","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.113.000016","article-title":"Mechanical unloading activates FOXO3 to trigger Bnip3-dependent cardiomyocyte atrophy","volume":"2","author":"Cao","year":"2013","journal-title":"J. Am. Heart Assoc."},{"issue":"Suppl. 1","key":"10.1016\/j.yjmcc.2025.02.010_bb0155","doi-asserted-by":"crossref","first-page":"S119","DOI":"10.2337\/diabetes.53.2007.S119","article-title":"Beta-cell glucose toxicity, lipotoxicity, and chronic oxidative stress in type 2 diabetes","volume":"53","author":"Robertson","year":"2004","journal-title":"Diabetes"},{"issue":"6","key":"10.1016\/j.yjmcc.2025.02.010_bb0160","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/jdi.12250","article-title":"Diabetic cardiomyopathy and its mechanisms: role of oxidative stress and damage","volume":"5","author":"Liu","year":"2014","journal-title":"J. Diabetes Investig."},{"issue":"6779","key":"10.1016\/j.yjmcc.2025.02.010_bb0165","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/35008121","article-title":"Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage","volume":"404","author":"Nishikawa","year":"2000","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.yjmcc.2025.02.010_bb0170","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1002\/ehf2.14224","article-title":"Diabetic cardiomyopathy: a brief summary on lipid toxicity","volume":"10","author":"Ke","year":"2023","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.yjmcc.2025.02.010_bb0175","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s44200-024-00062-8","article-title":"Oxidative stress and its biomarkers in cardiovascular diseases","volume":"30","author":"Valaitien\u0117","year":"2024","journal-title":"Artery Res."},{"key":"10.1016\/j.yjmcc.2025.02.010_bb0180","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.3390\/biom12091228","article-title":"Role of Reactive Oxygen Species in Glucose Metabolism Disorder in Diabetic Pancreatic-Cells","volume":"12","author":"Mukai","year":"2022","journal-title":"Biomolecules"},{"issue":"4","key":"10.1016\/j.yjmcc.2025.02.010_bb0185","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1136\/heartjnl-2017-311448","article-title":"Reactive oxygen species signalling in the diabetic heart: emerging prospect for therapeutic targeting","volume":"104","author":"Wilson","year":"2018","journal-title":"Heart"},{"issue":"7","key":"10.1016\/j.yjmcc.2025.02.010_bb0190","doi-asserted-by":"crossref","first-page":"3587","DOI":"10.3390\/ijms23073587","article-title":"Pathophysiology and treatment of diabetic cardiomyopathy and heart failure in patients with diabetes mellitus","volume":"23","author":"Nakamura","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.yjmcc.2025.02.010_bb0195","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1161\/01.RES.87.12.1123","article-title":"Myocardial cell death in human diabetes","volume":"87","author":"Frustaci","year":"2000","journal-title":"Circ. Res."},{"issue":"10","key":"10.1016\/j.yjmcc.2025.02.010_bb0200","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1089\/ars.2012.4604","article-title":"Angiotensin II-induced production of mitochondrial reactive oxygen species: potential mechanisms and relevance for cardiovascular disease","volume":"19","author":"Dikalov","year":"2013","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.yjmcc.2025.02.010_bb0205","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.947294","article-title":"Molecular and cellular mechanisms in diabetic heart failure: potential therapeutic targets","volume":"13","author":"Mengstie","year":"2022","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"9","key":"10.1016\/j.yjmcc.2025.02.010_bb0210","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.tcb.2020.05.004","article-title":"Endoplasmic reticulum (ER) stress response failure in diseases","volume":"30","author":"Bhattarai","year":"2020","journal-title":"Trends Cell Biol."},{"issue":"6","key":"10.1016\/j.yjmcc.2025.02.010_bb0215","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0039893","article-title":"Role of ER stress in ventricular contractile dysfunction in type 2 diabetes","volume":"7","author":"Takada","year":"2012","journal-title":"PloS One"},{"issue":"8A","key":"10.1016\/j.yjmcc.2025.02.010_bb0220","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1111\/j.1582-4934.2009.00833.x","article-title":"Diabetes- and angiotensin II-induced cardiac endoplasmic reticulum stress and cell death: metallothionein protection","volume":"13","author":"Xu","year":"2009","journal-title":"J. Cell. Mol. Med."},{"issue":"2","key":"10.1016\/j.yjmcc.2025.02.010_bb0225","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1093\/cvr\/cvy197","article-title":"Endoplasmic reticulum stress induces cardiac dysfunction through architectural modifications and alteration of mitochondrial function in cardiomyocytes","volume":"115","author":"Prola","year":"2019","journal-title":"Cardiovasc. Res."},{"issue":"17","key":"10.1016\/j.yjmcc.2025.02.010_bb0230","doi-asserted-by":"crossref","first-page":"6043","DOI":"10.3390\/ijms21176043","article-title":"Mitochondrial dysfunction in diabetic cardiomyopathy: the possible therapeutic roles of phenolic acids","volume":"21","author":"Jubaidi","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.yjmcc.2025.02.010_bb0235","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.2337\/db07-0481","article-title":"Mitochondrial energetics in the heart in obesity-related diabetes: direct evidence for increased uncoupled respiration and activation of uncoupling proteins","volume":"56","author":"Boudina","year":"2007","journal-title":"Diabetes"},{"issue":"20","key":"10.1016\/j.yjmcc.2025.02.010_bb0240","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1016\/j.jacc.2009.07.031","article-title":"Substrate-specific derangements in mitochondrial metabolism and redox balance in the atrium of the type 2 diabetic human heart","volume":"54","author":"Anderson","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.yjmcc.2025.02.010_bb0245","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.694864","article-title":"Mechanisms and therapeutic prospects of diabetic cardiomyopathy through the inflammatory response","volume":"12","author":"Kaur","year":"2021","journal-title":"Front. Physiol."},{"issue":"1","key":"10.1016\/j.yjmcc.2025.02.010_bb0250","doi-asserted-by":"crossref","first-page":"50","DOI":"10.15420\/ecr.2018.33.1","article-title":"The role of inflammation in diabetes: current concepts and future perspectives","volume":"14","author":"Tsalamandris","year":"2019","journal-title":"Eur. Cardiol."},{"issue":"14","key":"10.1016\/j.yjmcc.2025.02.010_bb0255","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1113\/JP276747","article-title":"Cardiomyopathy in obesity, insulin resistance and diabetes","volume":"598","author":"Nakamura","year":"2020","journal-title":"J. Physiol."},{"key":"10.1016\/j.yjmcc.2025.02.010_bb0260","article-title":"Profile of crosstalk between glucose and lipid metabolic disturbance and diabetic cardiomyopathy: inflammation and oxidative stress","volume":"13","author":"Chen","year":"2022","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.yjmcc.2025.02.010_bb0265","doi-asserted-by":"crossref","first-page":"519","DOI":"10.3389\/fphys.2017.00519","article-title":"NLRP3 Inflammasome as a molecular marker in diabetic cardiomyopathy","volume":"8","author":"Luo","year":"2017","journal-title":"Front. Physiol."},{"key":"10.1016\/j.yjmcc.2025.02.010_bb0270","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nm.2279","article-title":"The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance","volume":"17","author":"Vandanmagsar","year":"2011","journal-title":"Nat. Med."},{"issue":"8","key":"10.1016\/j.yjmcc.2025.02.010_bb0275","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0104771","article-title":"NLRP3 gene silencing ameliorates diabetic cardiomyopathy in a type 2 diabetes rat model","volume":"9","author":"Luo","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.yjmcc.2025.02.010_bb0280","first-page":"2214","article-title":"Coronary microvascular dysfunction in overt diabetic cardiomyopathy","volume":"p19-23","author":"Bratis","year":"2014","journal-title":"IJC Metab. Endocrine"},{"issue":"5","key":"10.1016\/j.yjmcc.2025.02.010_bb0285","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1291\/hypres.30.439","article-title":"Angiotensin II type 1 receptor blocker attenuates myocardial remodeling and preserves diastolic function in diabetic heart","volume":"30","author":"Tsutsui","year":"2007","journal-title":"Hypertens. Res."},{"issue":"1","key":"10.1016\/j.yjmcc.2025.02.010_bb0290","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1161\/CIRCIMAGING.111.965608","article-title":"Association between diffuse myocardial fibrosis by cardiac magnetic resonance contrast-enhanced T\u2081 mapping and subclinical myocardial dysfunction in diabetic patients: a pilot study","volume":"5","author":"Ng","year":"2012","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"10.1016\/j.yjmcc.2025.02.010_bb0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.113904","article-title":"Fibrosis of the diabetic heart: clinical significance, molecular mechanisms, and therapeutic opportunities","volume":"176","author":"Tuleta","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.yjmcc.2025.02.010_bb0300","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/1475-2840-11-73","article-title":"Cardiac fibrosis and dysfunction in experimental diabetic cardiomyopathy are ameliorated by alpha-lipoic acid","volume":"11","author":"Li","year":"2012","journal-title":"Cardiovasc. Diabetol."},{"issue":"1","key":"10.1016\/j.yjmcc.2025.02.010_bb0305","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12933-017-0506-x","article-title":"Diagnostic approaches for diabetic cardiomyopathy","volume":"16","author":"Lorenzo-Almor\u00f3s","year":"2017","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.yjmcc.2025.02.010_bb0310","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/j.amjcard.2004.07.143","article-title":"Three-dimensional assessment of left ventricular systolic strain in patients with type 2 diabetes mellitus, diastolic dysfunction, and normal ejection fraction","volume":"94","author":"Fonseca","year":"2004","journal-title":"Am. J. Cardiol."},{"issue":"4","key":"10.1016\/j.yjmcc.2025.02.010_bb0315","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1161\/CIRCRESAHA.117.311586","article-title":"Diabetic cardiomyopathy: An update of mechanisms contributing to this clinical entity","volume":"122","author":"Jia","year":"2018","journal-title":"Circ. Res."},{"issue":"2","key":"10.1016\/j.yjmcc.2025.02.010_bb0320","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1001\/jama.289.2.194","article-title":"Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic","volume":"289","author":"Redfield","year":"2003","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.yjmcc.2025.02.010_bb0325","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.jphs.2014.12.007","article-title":"Sitagliptin alleviated myocardial remodeling of the left ventricle and improved cardiac diastolic dysfunction in diabetic rats","volume":"127","author":"Liu","year":"2015","journal-title":"J. Pharmacol. Sci."},{"issue":"2\u20133","key":"10.1016\/j.yjmcc.2025.02.010_bb0330","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1900\/RDS.2012.9.82","article-title":"Dyslipidemia and diabetes: reciprocal impact of impaired lipid metabolism and beta-cell dysfunction on micro- and macrovascular complications","volume":"9","author":"Bardini","year":"2012","journal-title":"Rev. Diabet. Stud."},{"issue":"2","key":"10.1016\/j.yjmcc.2025.02.010_bb0335","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0008-6363(02)00513-8","article-title":"Correlation of functional and structural alterations of the coronary arterioles during development of type II diabetes mellitus in rats","volume":"56","author":"Yu","year":"2002","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.yjmcc.2025.02.010_bb0340","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.yjmcc.2012.06.018","article-title":"Myocardial triacylglycerol metabolism","volume":"55","author":"Kienesberger","year":"2013","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"1","key":"10.1016\/j.yjmcc.2025.02.010_bb0345","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1152\/physrev.00015.2009","article-title":"Myocardial fatty acid metabolism in health and disease","volume":"90","author":"Lopaschuk","year":"2010","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.yjmcc.2025.02.010_bb0350","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev-nutr-071813-105541","article-title":"Acyl-CoA metabolism and partitioning","volume":"34","author":"Grevengoed","year":"2014","journal-title":"Annu. Rev. Nutr."},{"key":"10.1016\/j.yjmcc.2025.02.010_bb0355","article-title":"The role of incomplete fatty acid \u03b2-oxidation in the development of cardiac insulin resistance. Cardiac energy metabolism in health and disease","volume":"11","author":"Ussher","year":"2014","journal-title":"Adv. Biochem. Health Disease"},{"issue":"12","key":"10.1016\/j.yjmcc.2025.02.010_bb0360","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1194\/jlr.M017939","article-title":"Perilipin 5, a lipid droplet-associated protein, provides physical and metabolic linkage to mitochondria","volume":"52","author":"Wang","year":"2011","journal-title":"J. Lipid Res."},{"issue":"5700","key":"10.1016\/j.yjmcc.2025.02.010_bb0365","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1126\/science.1100747","article-title":"Fat mobilization in adipose tissue is promoted by adipose triglyceride lipase","volume":"306","author":"Zimmermann","year":"2004","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.yjmcc.2025.02.010_bb0370","doi-asserted-by":"crossref","first-page":"4806","DOI":"10.1074\/jbc.M110355200","article-title":"Hormone-sensitive lipase deficiency in mice causes diglyceride accumulation in adipose tissue, muscle, and testis","volume":"277","author":"Haemmerle","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"9","key":"10.1016\/j.yjmcc.2025.02.010_bb0375","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1139\/o88-116","article-title":"Monoacylglycerol lipase activity in cardiac myocytes","volume":"66","author":"Severson","year":"1988","journal-title":"Biochem. Cell Biol."},{"issue":"1","key":"10.1016\/j.yjmcc.2025.02.010_bb0380","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1432-1033.1997.00001.x","article-title":"The mitochondrial carnitine palmitoyltransferase system. From concept to molecular analysis","volume":"244","author":"McGarry","year":"1997","journal-title":"Eur. J. Biochem."},{"issue":"5","key":"10.1016\/j.yjmcc.2025.02.010_bb0385","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1161\/CIRCRESAHA.111.246371","article-title":"Pyridine nucleotide regulation of cardiac intermediary metabolism","volume":"111","author":"Ussher","year":"2012","journal-title":"Circ. Res."},{"key":"10.1016\/j.yjmcc.2025.02.010_bb0390","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1101\/sqb.2011.76.011965","article-title":"Transcriptional control of cardiac fuel metabolism and mitochondrial function","volume":"76","author":"Leone","year":"2011","journal-title":"Cold Spring Harb. Symp. Quant. Biol."},{"issue":"6","key":"10.1016\/j.yjmcc.2025.02.010_bb0395","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.yjmcc.2008.03.021","article-title":"The PPAR trio: regulators of myocardial energy metabolism in health and disease","volume":"44","author":"Madrazo","year":"2008","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"7","key":"10.1016\/j.yjmcc.2025.02.010_bb0400","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1194\/jlr.R082933","article-title":"Dynamic role of the transmembrane glycoprotein CD36 (SR-B2) in cellular fatty acid uptake and utilization","volume":"59","author":"Glatz","year":"2018","journal-title":"J. Lipid Res."},{"issue":"8","key":"10.1016\/j.yjmcc.2025.02.010_bb0405","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1161\/01.RES.0000264104.25265.b6","article-title":"CD36 deficiency rescues lipotoxic cardiomyopathy","volume":"100","author":"Yang","year":"2007","journal-title":"Circ. Res."},{"issue":"1","key":"10.1016\/j.yjmcc.2025.02.010_bb0410","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1042\/BJ20120060","article-title":"CD36 inhibition prevents lipid accumulation and contractile dysfunction in rat cardiomyocytes","volume":"448","author":"Angin","year":"2012","journal-title":"Biochem. J."},{"issue":"1","key":"10.1016\/j.yjmcc.2025.02.010_bb0415","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00424-003-1199-4","article-title":"Regulation of cardiac long-chain fatty acid and glucose uptake by translocation of substrate transporters","volume":"448","author":"Luiken","year":"2004","journal-title":"Pflugers Arch."},{"issue":"2","key":"10.1016\/j.yjmcc.2025.02.010_bb0420","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/cvr\/cvn116","article-title":"Regulation of sarcolemmal glucose and fatty acid transporters in cardiac disease","volume":"79","author":"Schwenk","year":"2008","journal-title":"Cardiovasc. Res."},{"issue":"2","key":"10.1016\/j.yjmcc.2025.02.010_bb0425","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1079\/PNS2004331","article-title":"Regulation of fatty acid transport by fatty acid translocase\/CD36","volume":"63","author":"Bonen","year":"2004","journal-title":"Proc. Nutr. Soc."},{"issue":"6","key":"10.1016\/j.yjmcc.2025.02.010_bb0430","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s10557-006-0582-8","article-title":"Regulation of sarcolemmal transport of substrates in the healthy and diseased heart","volume":"20","author":"Glatz","year":"2006","journal-title":"Cardiovasc. Drugs Ther."},{"issue":"9","key":"10.1016\/j.yjmcc.2025.02.010_bb0435","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1007\/s00125-007-0735-8","article-title":"Cardiac contractile dysfunction in insulin-resistant rats fed a high-fat diet is associated with elevated CD36-mediated fatty acid uptake and esterification","volume":"50","author":"Ouwens","year":"2007","journal-title":"Diabetologia"},{"issue":"7","key":"10.1016\/j.yjmcc.2025.02.010_bb0440","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.2337\/diabetes.53.7.1655","article-title":"Enhanced sarcolemmal FAT\/CD36 content and triacylglycerol storage in cardiac myocytes from obese zucker rats","volume":"53","author":"Coort","year":"2004","journal-title":"Diabetes"},{"issue":"44","key":"10.1016\/j.yjmcc.2025.02.010_bb0445","doi-asserted-by":"crossref","first-page":"40567","DOI":"10.1074\/jbc.M100052200","article-title":"Increased rates of fatty acid uptake and plasmalemmal fatty acid transporters in obese Zucker rats","volume":"276","author":"Luiken","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yjmcc.2025.02.010_bb0450","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/89969","article-title":"A link between diabetes and atherosclerosis: glucose regulates expression of CD36 at the level of translation","author":"Griffin","year":"2001","journal-title":"Nat. Med."},{"issue":"9","key":"10.1016\/j.yjmcc.2025.02.010_bb0455","doi-asserted-by":"crossref","first-page":"3455","DOI":"10.1128\/MCB.26.9.3455-3467.2006","article-title":"FATP1 is an insulin-sensitive fatty acid transporter involved in diet-induced obesity","volume":"26","author":"Wu","year":"2006","journal-title":"Mol. Cell. Biol."},{"issue":"2","key":"10.1016\/j.yjmcc.2025.02.010_bb0460","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1161\/01.RES.0000154079.20681.B9","article-title":"Transgenic expression of fatty acid transport protein 1 in the heart causes lipotoxic cardiomyopathy","volume":"96","author":"Chiu","year":"2005","journal-title":"Circ. Res."},{"issue":"3","key":"10.1016\/j.yjmcc.2025.02.010_bb0465","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1172\/JCI16751","article-title":"Lipoprotein lipase (LpL) on the surface of cardiomyocytes increases lipid uptake and produces a cardiomyopathy","volume":"111","author":"Yagyu","year":"2003","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.yjmcc.2025.02.010_bb0470","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1161\/HYPERTENSIONAHA.110.160655","article-title":"A murine model of isolated cardiac steatosis leads to cardiomyopathy","volume":"57","author":"Glenn","year":"2011","journal-title":"Hypertension"},{"issue":"52","key":"10.1016\/j.yjmcc.2025.02.010_bb0475","doi-asserted-by":"crossref","first-page":"36312","DOI":"10.1074\/jbc.M109.049817","article-title":"DGAT1 expression increases heart triglyceride content but ameliorates lipotoxicity","volume":"284","author":"Liu","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.yjmcc.2025.02.010_bb0480","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1194\/jlr.M024208","article-title":"Diacylglycerol acyl transferase 1 overexpression detoxifies cardiac lipids in PPAR\u03b3 transgenic mice","volume":"53","author":"Liu","year":"2012","journal-title":"J. Lipid Res."},{"issue":"43","key":"10.1016\/j.yjmcc.2025.02.010_bb0485","doi-asserted-by":"crossref","first-page":"29881","DOI":"10.1074\/jbc.M114.601864","article-title":"Cardiomyocyte-specific loss of diacylglycerol acyltransferase 1 (DGAT1) reproduces the abnormalities in lipids found in severe heart failure","volume":"289","author":"Liu","year":"2014","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.yjmcc.2025.02.010_bb0490","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1161\/CIRCRESAHA.117.311307","article-title":"Mitochondrial reactive oxygen species in Lipotoxic hearts induce post-translational modifications of AKAP121, DRP1, and OPA1 that promote mitochondrial fission","volume":"122","author":"Tsushima","year":"2018","journal-title":"Circ. Res."},{"issue":"5774","key":"10.1016\/j.yjmcc.2025.02.010_bb0495","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1126\/science.1123965","article-title":"Defective lipolysis and altered energy metabolism in mice lacking adipose triglyceride lipase","volume":"312","author":"Haemmerle","year":"2006","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.yjmcc.2025.02.010_bb0500","doi-asserted-by":"crossref","first-page":"E1109","DOI":"10.1152\/ajpendo.00016.2008","article-title":"Cardiac overexpression of hormone-sensitive lipase inhibits myocardial steatosis and fibrosis in streptozotocin diabetic mice","volume":"294","author":"Ueno","year":"2008","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"12","key":"10.1016\/j.yjmcc.2025.02.010_bb0505","doi-asserted-by":"crossref","first-page":"5341","DOI":"10.1210\/en.2005-0938","article-title":"Reduced cardiac efficiency and altered substrate metabolism precedes the onset of hyperglycemia and contractile dysfunction in two mouse models of insulin resistance and obesity","volume":"146","author":"Buchanan","year":"2005","journal-title":"Endocrinology"},{"issue":"8","key":"10.1016\/j.yjmcc.2025.02.010_bb0510","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.2337\/diabetes.51.8.2587","article-title":"Impaired long-chain fatty acid oxidation and contractile dysfunction in the obese Zucker rat heart","volume":"51","author":"Young","year":"2002","journal-title":"Diabetes"},{"issue":"1\u20132","key":"10.1016\/j.yjmcc.2025.02.010_bb0515","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.bbrc.2015.10.162","article-title":"Impaired fatty acid oxidation as a cause for lipotoxicity in cardiomyocytes","volume":"468","author":"Haffar","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"10","key":"10.1016\/j.yjmcc.2025.02.010_bb0520","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1093\/cvr\/cvad100","article-title":"Cardiac lipid metabolism, mitochondrial function, and heart failure","volume":"119","author":"Da Dalt","year":"2023","journal-title":"Cardiovasc. Res."},{"issue":"2","key":"10.1016\/j.yjmcc.2025.02.010_bb0525","doi-asserted-by":"crossref","first-page":"466","DOI":"10.2337\/diabetes.55.02.06.db05-1164","article-title":"Increased myocardial oxygen consumption reduces cardiac efficiency in diabetic mice","volume":"55","author":"How","year":"2006","journal-title":"Diabetes"},{"issue":"3","key":"10.1016\/j.yjmcc.2025.02.010_bb0530","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.bbalip.2009.09.023","article-title":"Lipotoxicity in the heart","volume":"1801","author":"Wende","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"issue":"10","key":"10.1016\/j.yjmcc.2025.02.010_bb0535","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1161\/CIRCULATIONAHA.106.645614","article-title":"Cardiac steatosis in diabetes mellitus: a 1H-magnetic resonance spectroscopy study","volume":"116","author":"McGavock","year":"2007","journal-title":"Circulation"},{"issue":"22","key":"10.1016\/j.yjmcc.2025.02.010_bb0540","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1016\/j.jacc.2008.07.062","article-title":"Myocardial steatosis is an independent predictor of diastolic dysfunction in type 2 diabetes mellitus","volume":"52","author":"Rijzewijk","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.yjmcc.2025.02.010_bb0545","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/2122856","article-title":"Plin5, a new target in diabetic cardiomyopathy","volume":"2022","author":"Cui","year":"2022","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"18","key":"10.1016\/j.yjmcc.2025.02.010_bb0550","doi-asserted-by":"crossref","first-page":"15707","DOI":"10.1074\/jbc.M110.207779","article-title":"Unique regulation of adipose triglyceride lipase (ATGL) by perilipin 5, a lipid droplet-associated protein","volume":"286","author":"Wang","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.yjmcc.2025.02.010_bb0555","first-page":"339","article-title":"Low cardiac lipolysis reduces mitochondrial fission and prevents lipotoxic heart dysfunction in Perilipin 5 mutant mice","volume":"116","author":"Kolleritsch","year":"2020","journal-title":"Cardiovasc. Res."},{"issue":"4","key":"10.1016\/j.yjmcc.2025.02.010_bb0560","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1194\/jlr.M034710","article-title":"Cardiac-specific overexpression of perilipin 5 provokes severe cardiac steatosis via the formation of a lipolytic barrier","volume":"54","author":"Pollak","year":"2013","journal-title":"J. Lipid Res."},{"issue":"4","key":"10.1016\/j.yjmcc.2025.02.010_bb0565","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1194\/jlr.M032466","article-title":"Cardiomyocyte-specific perilipin 5 overexpression leads to myocardial steatosis and modest cardiac dysfunction","volume":"54","author":"Wang","year":"2013","journal-title":"J. Lipid Res."},{"issue":"5","key":"10.1016\/j.yjmcc.2025.02.010_bb0570","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.2337\/db12-0927","article-title":"Myocardial adipose triglyceride lipase overexpression protects diabetic mice from the development of lipotoxic cardiomyopathy","volume":"62","author":"Pulinilkunnil","year":"2013","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.yjmcc.2025.02.010_bb0575","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1186\/s12944-018-0872-8","article-title":"Profile of cardiac lipid metabolism in STZ-induced diabetic mice","volume":"17","author":"Li","year":"2018","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.yjmcc.2025.02.010_bb0580","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.yjmcc.2014.12.001","article-title":"Mitochondrial remodeling in mice with cardiomyocyte-specific lipid overload","volume":"79","author":"Elezaby","year":"2015","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"1","key":"10.1016\/j.yjmcc.2025.02.010_bb0585","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1093\/cvr\/cvq266","article-title":"Cardiac diacylglycerol accumulation in high fat-fed mice is associated with impaired insulin-stimulated glucose oxidation","volume":"89","author":"Zhang","year":"2011","journal-title":"Cardiovasc. Res."},{"issue":"2","key":"10.1016\/j.yjmcc.2025.02.010_bb0590","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s11897-013-0133-0","article-title":"Cardiac lipotoxicity: molecular pathways and therapeutic implications","volume":"10","author":"Drosatos","year":"2013","journal-title":"Curr. Heart Fail. Rep."},{"issue":"4","key":"10.1016\/j.yjmcc.2025.02.010_bb0595","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.hfc.2012.06.003","article-title":"Sphingolipids, lipotoxic cardiomyopathy, and cardiac failure","volume":"8","author":"Park","year":"2012","journal-title":"Heart Fail. Clin."},{"issue":"10","key":"10.1016\/j.yjmcc.2025.02.010_bb0600","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1016\/j.celrep.2018.02.034","article-title":"Ceramide-protein interactions modulate ceramide-associated Lipotoxic cardiomyopathy","volume":"22","author":"Walls","year":"2018","journal-title":"Cell Rep."},{"issue":"6","key":"10.1016\/j.yjmcc.2025.02.010_bb0605","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s00395-014-0445-6","article-title":"Ceramide-mediated depression in cardiomyocyte contractility through PKC activation and modulation of myofilament protein phosphorylation","volume":"109","author":"Simon","year":"2014","journal-title":"Basic Res. Cardiol."},{"issue":"4","key":"10.1016\/j.yjmcc.2025.02.010_bb0610","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1073\/pnas.97.4.1784","article-title":"Lipotoxic heart disease in obese rats: implications for human obesity","volume":"97","author":"Zhou","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"11","key":"10.1016\/j.yjmcc.2025.02.010_bb0615","doi-asserted-by":"crossref","first-page":"3919","DOI":"10.1172\/JCI63888","article-title":"Ceramide synthase 5 mediates lipid-induced autophagy and hypertrophy in cardiomyocytes","volume":"122","author":"Russo","year":"2012","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.yjmcc.2025.02.010_bb0620","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1096\/fj.201700300R","article-title":"Lipotoxic very-long-chain ceramides cause mitochondrial dysfunction, oxidative stress, and cell death in cardiomyocytes","volume":"32","author":"Law","year":"2018","journal-title":"FASEB J."},{"issue":"9\u201310","key":"10.1016\/j.yjmcc.2025.02.010_bb0625","first-page":"995","article-title":"Plasma ceramides are elevated in female children and adolescents with type 2 diabetes","volume":"26","author":"Lopez","year":"2013","journal-title":"J. Pediatr. Endocrinol. Metab."},{"issue":"11","key":"10.1016\/j.yjmcc.2025.02.010_bb0630","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.jacc.2020.01.018","article-title":"Lipid accumulation in hearts transplanted from nondiabetic donors to diabetic recipients","volume":"75","author":"Marfella","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1","key":"10.1016\/j.yjmcc.2025.02.010_bb0635","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1194\/jlr.M900002-JLR200","article-title":"Myocardium of type 2 diabetic and obese patients is characterized by alterations in sphingolipid metabolic enzymes but not by accumulation of ceramide","volume":"51","author":"Baranowski","year":"2010","journal-title":"J. Lipid Res."},{"issue":"13","key":"10.1016\/j.yjmcc.2025.02.010_bb0640","doi-asserted-by":"crossref","first-page":"5234","DOI":"10.1021\/bi047773a","article-title":"Accumulation of long-chain acylcarnitine and 3-hydroxy acylcarnitine molecular species in diabetic myocardium: identification of alterations in mitochondrial fatty acid processing in diabetic myocardium by shotgun lipidomics","volume":"44","author":"Su","year":"2005","journal-title":"Biochemistry"},{"issue":"12","key":"10.1016\/j.yjmcc.2025.02.010_bb0645","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1194\/jlr.M600299-JLR200","article-title":"Disruption of endoplasmic reticulum structure and integrity in lipotoxic cell death","volume":"47","author":"Borradaile","year":"2006","journal-title":"J. Lipid Res."},{"issue":"1","key":"10.1016\/j.yjmcc.2025.02.010_bb0650","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.bbrc.2005.08.088","article-title":"Oleate prevents palmitate-induced cytotoxic stress in cardiac myocytes","volume":"336","author":"Miller","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"16","key":"10.1016\/j.yjmcc.2025.02.010_bb0655","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1016\/j.jacc.2009.04.074","article-title":"Altered myocardial substrate metabolism and decreased diastolic function in nonischemic human diabetic cardiomyopathy: studies with cardiac positron emission tomography and magnetic resonance imaging","volume":"54","author":"Rijzewijk","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"issue":"3","key":"10.1016\/j.yjmcc.2025.02.010_bb0660","doi-asserted-by":"crossref","first-page":"826","DOI":"10.14336\/AD.2020.1217","article-title":"CD36 signaling in diabetic cardiomyopathy","volume":"12","author":"Zhang","year":"2021","journal-title":"Aging Dis."},{"issue":"3","key":"10.1016\/j.yjmcc.2025.02.010_bb0665","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1152\/physrev.00027.2013","article-title":"Physiological functions of peroxisome proliferator-activated receptor \u03b2","volume":"94","author":"Neels","year":"2014","journal-title":"Physiol. Rev."},{"issue":"1","key":"10.1016\/j.yjmcc.2025.02.010_bb0670","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/nrendo.2016.135","article-title":"PPARs in obesity-induced T2DM, dyslipidaemia and NAFLD","volume":"13","author":"Gross","year":"2017","journal-title":"Nat. Rev. Endocrinol."},{"issue":"1","key":"10.1016\/j.yjmcc.2025.02.010_bb0675","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1172\/JCI0214080","article-title":"The cardiac phenotype induced by PPARalpha overexpression mimics that caused by diabetes mellitus","volume":"109","author":"Finck","year":"2002","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.yjmcc.2025.02.010_bb0680","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1073\/pnas.0336724100","article-title":"A critical role for PPARalpha-mediated lipotoxicity in the pathogenesis of diabetic cardiomyopathy: modulation by dietary fat content","volume":"100","author":"Finck","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.yjmcc.2025.02.010_bb0685","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1093\/cvr\/cvn001","article-title":"Cardiac hypertrophy is enhanced in PPAR alpha\u2212\/\u2212 mice in response to chronic pressure overload","volume":"78","author":"Smeets","year":"2008","journal-title":"Cardiovasc. Res."},{"issue":"1\u20132","key":"10.1016\/j.yjmcc.2025.02.010_bb0690","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s11010-006-9140-8","article-title":"Prolonged AMPK activation increases the expression of fatty acid transporters in cardiac myocytes and perfused hearts","volume":"288","author":"Chabowski","year":"2006","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.yjmcc.2025.02.010_bb0695","doi-asserted-by":"crossref","DOI":"10.1016\/j.prostaglandins.2022.106698","article-title":"Lipoxin and glycation in SREBP signaling: insight into diabetic cardiomyopathy and associated lipotoxicity","volume":"164","author":"Thakur","year":"2023","journal-title":"Prostaglandins Other Lipid Mediat."},{"issue":"1","key":"10.1016\/j.yjmcc.2025.02.010_bb0700","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.bbrc.2009.09.108","article-title":"Suppression of cardiac phosphatidate phosphohydrolase 1 activity and lipin mRNA expression in Zucker diabetic fatty rats and humans with type 2 diabetes mellitus","volume":"390","author":"Burgdorf","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"11","key":"10.1016\/j.yjmcc.2025.02.010_bb0705","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1038\/nm788","article-title":"Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase","volume":"8","author":"Yamauchi","year":"2002","journal-title":"Nat. Med."},{"issue":"3","key":"10.1016\/j.yjmcc.2025.02.010_bb0710","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/nm1557","article-title":"Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions","volume":"13","author":"Yamauchi","year":"2007","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.yjmcc.2025.02.010_bb0715","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3109\/07435800.2013.879165","article-title":"Adiponectin receptor 1 overexpression reduces lipid accumulation and hypertrophy in the heart of diet-induced obese mice--possible involvement of oxidative stress and autophagy","volume":"39","author":"Chou","year":"2014","journal-title":"Endocr. Res."},{"issue":"7","key":"10.1016\/j.yjmcc.2025.02.010_bb0720","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0068697","article-title":"Adiponectin modulates oxidative stress-induced autophagy in cardiomyocytes","volume":"8","author":"Essick","year":"2013","journal-title":"PloS One"},{"issue":"3","key":"10.1016\/j.yjmcc.2025.02.010_bb0725","doi-asserted-by":"crossref","first-page":"H984","DOI":"10.1152\/ajpheart.00428.2011","article-title":"Adiponectin mediates cardioprotection in oxidative stress-induced cardiac myocyte remodeling","volume":"301","author":"Essick","year":"2011","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"7","key":"10.1016\/j.yjmcc.2025.02.010_bb0730","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1161\/CIRCRESAHA.118.312498","article-title":"Sirtuins and NAD+ in the development and treatment of metabolic and cardiovascular diseases","volume":"123","author":"Kane","year":"2018","journal-title":"Circ. Res."},{"issue":"8","key":"10.1016\/j.yjmcc.2025.02.010_bb0735","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202301012R","article-title":"SIRT6: a potential therapeutic target for diabetic cardiomyopathy","volume":"37","author":"Wu","year":"2023","journal-title":"FASEB J."},{"issue":"9","key":"10.1016\/j.yjmcc.2025.02.010_bb0740","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109190","article-title":"SIRT6 transcriptionally regulates fatty acid transport by suppressing PPAR\u03b3","volume":"35","author":"Khan","year":"2021","journal-title":"Cell Rep."},{"issue":"10","key":"10.1016\/j.yjmcc.2025.02.010_bb0745","doi-asserted-by":"crossref","first-page":"10872","DOI":"10.1096\/fj.201900767R","article-title":"The nuclear and mitochondrial sirtuins, Sirt6 and Sirt3, regulate each other's activity and protect the heart from developing obesity-mediated diabetic cardiomyopathy","volume":"33","author":"Kanwal","year":"2019","journal-title":"FASEB J."},{"key":"10.1016\/j.yjmcc.2025.02.010_bb0750","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103184","article-title":"Sirt5 improves cardiomyocytes fatty acid metabolism and ameliorates cardiac lipotoxicity in diabetic cardiomyopathy via CPT2 de-succinylation","volume":"73","author":"Wu","year":"2024","journal-title":"Redox Biol."},{"key":"10.1016\/j.yjmcc.2025.02.010_bb0755","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2020.113525","article-title":"Application of untargeted lipidomics based on UHPLC-high resolution tandem MS analysis to profile the lipid metabolic disturbances in the heart of diabetic cardiomyopathy mice","volume":"190","author":"Xu","year":"2020","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.yjmcc.2025.02.010_bb0760","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.freeradbiomed.2018.10.445","article-title":"GCN2 deficiency ameliorates cardiac dysfunction in diabetic mice by reducing lipotoxicity and oxidative stress","volume":"130","author":"Feng","year":"2019","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.yjmcc.2025.02.010_bb0765","doi-asserted-by":"crossref","first-page":"12568","DOI":"10.3389\/jpps.2024.12568","article-title":"Lipotoxicity as a therapeutic target in obesity and diabetic cardiomyopathy","volume":"27","author":"Nakamura","year":"2024","journal-title":"J. Pharm. Pharm. Sci."},{"issue":"2","key":"10.1016\/j.yjmcc.2025.02.010_bb0770","doi-asserted-by":"crossref","first-page":"996","DOI":"10.3390\/ijms23020996","article-title":"Deranged myocardial fatty acid metabolism in heart failure","volume":"23","author":"Yamamoto","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.yjmcc.2025.02.010_bb0775","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.3390\/ijms25021211","article-title":"Metabolic flexibility of the heart: the role of fatty acid metabolism in health, heart failure, and Cardiometabolic diseases","volume":"25","author":"Actis Dato","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.yjmcc.2025.02.010_bb0780","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1253\/circj.CJ-21-0848","article-title":"Pathophysiology of coronary microvascular dysfunction","volume":"86","author":"Crea","year":"2022","journal-title":"Circ. J."},{"key":"10.1016\/j.yjmcc.2025.02.010_bb0785","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.742178","article-title":"Inflammation in metabolic cardiomyopathy","volume":"8","author":"Wenzl","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"issue":"3","key":"10.1016\/j.yjmcc.2025.02.010_bb0790","doi-asserted-by":"crossref","first-page":"H949","DOI":"10.1152\/ajpheart.00226.2001","article-title":"Cardiac function and metabolism in type 2 diabetic mice after treatment with BM 17.0744, a novel PPAR-alpha activator","volume":"283","author":"Aasum","year":"2002","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"14","key":"10.1016\/j.yjmcc.2025.02.010_bb0795","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1096\/fj.04-2263com","article-title":"Intramyocardial lipid accumulation in the failing human heart resembles the lipotoxic rat heart","volume":"18","author":"Sharma","year":"2004","journal-title":"FASEB J."},{"issue":"6","key":"10.1016\/j.yjmcc.2025.02.010_bb0800","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.102521","article-title":"Canagliflozin attenuates lipotoxicity in cardiomyocytes and protects diabetic mouse hearts by inhibiting the mTOR\/HIF-1\u03b1 pathway","volume":"24","author":"Sun","year":"2021","journal-title":"iScience"},{"issue":"1","key":"10.1016\/j.yjmcc.2025.02.010_bb0805","doi-asserted-by":"crossref","first-page":"858","DOI":"10.3390\/ijms24010858","article-title":"Canagliflozin attenuates lipotoxicity in cardiomyocytes by inhibiting inflammation and Ferroptosis through activating AMPK pathway","volume":"24","author":"Zhang","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.yjmcc.2025.02.010_bb0810","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.104626","article-title":"Therapeutic potential of polyphenols in cardiovascular diseases: regulation of mTOR signaling pathway","volume":"152","author":"Sanches-Silva","year":"2020","journal-title":"Pharmacol. Res."},{"issue":"2","key":"10.1016\/j.yjmcc.2025.02.010_bb0815","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1161\/HYPERTENSIONAHA.118.10845","article-title":"Hypoxia-induced Mitogenic factor promotes cardiac hypertrophy via calcium-dependent and hypoxia-inducible factor-1\u03b1 mechanisms","volume":"72","author":"Kumar","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.yjmcc.2025.02.010_bb0820","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1228646","article-title":"Protective effect of empagliflozin against palmitate-induced lipotoxicity through AMPK in H9c2 cells","volume":"14","author":"Song","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.yjmcc.2025.02.010_bb0825","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2019.113677","article-title":"Empagliflozin reduces the levels of CD36 and cardiotoxic lipids while improving autophagy in the hearts of Zucker diabetic fatty rats","volume":"170","author":"Arag\u00f3n-Herrera","year":"2019","journal-title":"Biochem. Pharmacol."},{"issue":"5","key":"10.1016\/j.yjmcc.2025.02.010_bb0830","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1080\/14728222.2021.1941865","article-title":"CD36 as a target for metabolic modulation therapy in cardiac disease","volume":"25","author":"Glatz","year":"2021","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.yjmcc.2025.02.010_bb0835","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.730623","article-title":"Dapagliflozin mediates Plin5\/PPAR\u03b1 signaling Axis to attenuate cardiac hypertrophy","volume":"12","author":"Yu","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.yjmcc.2025.02.010_bb0840","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1056\/NEJMoa1611925","article-title":"CANVAS program collaborative group. Canagliflozin and cardiovascular and renal events in type 2 diabetes","volume":"377","author":"Neal","year":"2017","journal-title":"NEngl. J. Med."},{"key":"10.1016\/j.yjmcc.2025.02.010_bb0845","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"EMPA-REG OUTCOME investigators. Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes","volume":"373","author":"Zinman","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.yjmcc.2025.02.010_bb0850","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1056\/NEJMoa1812389","article-title":"DECLARE\u2013TIMI 58 investigators. Dapagliflozin and cardiovascular outcomes in type 2 diabetes","volume":"380","author":"Wiviott","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.yjmcc.2025.02.010_bb0855","doi-asserted-by":"crossref","DOI":"10.1111\/acel.12763","article-title":"Glucagon-like peptide-1 ameliorates cardiac lipotoxicity in diabetic cardiomyopathy via the PPAR\u03b1 pathway","volume":"17","author":"Wu","year":"2018","journal-title":"Aging Cell"},{"key":"10.1016\/j.yjmcc.2025.02.010_bb0860","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1603827","article-title":"Liraglutide and cardiovascular outcomes in type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.yjmcc.2025.02.010_bb0865","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1056\/NEJMoa1607141","article-title":"Semaglutide and cardiovascular outcomes in patients with type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.yjmcc.2025.02.010_bb0870","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12933-015-0173-8","article-title":"Targeting metabolic disturbance in the diabetic heart","volume":"14","author":"Fuentes-Antr\u00e1s","year":"2015","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.yjmcc.2025.02.010_bb0875","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.114209","article-title":"A novel oral glucagon-like peptide 1 receptor agonist protects against diabetic cardiomyopathy via alleviating cardiac lipotoxicity induced mitochondria dysfunction","volume":"182","author":"Qian","year":"2020","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.yjmcc.2025.02.010_bb0880","doi-asserted-by":"crossref","first-page":"66","DOI":"10.12997\/jla.2020.9.1.66","article-title":"CD36 (SR-B2) as a target to treat lipid overload-induced cardiac dysfunction","volume":"9","author":"Glatz","year":"2020","journal-title":"J. Lipid Atheroscler."},{"issue":"1","key":"10.1016\/j.yjmcc.2025.02.010_bb0885","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.plefa.2012.04.009","article-title":"CD36 as a target to prevent cardiac lipotoxicity and insulin resistance","volume":"88","author":"Glatz","year":"2013","journal-title":"Prostaglandins Leukotrienes Essential Fatty Acids"},{"issue":"1","key":"10.1016\/j.yjmcc.2025.02.010_bb0890","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/cvr\/cvaa319","article-title":"The role of CD36 in cardiovascular disease","volume":"118","author":"Shu","year":"2022","journal-title":"Cardiovasc. Res."},{"issue":"5","key":"10.1016\/j.yjmcc.2025.02.010_bb0895","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1142\/S0192415X19500496","article-title":"Antidiabetic potential of flavonoids from traditional chinese medicine: a review","volume":"47","author":"Bai","year":"2024","journal-title":"Am. J. Chin. Med."},{"issue":"6","key":"10.1016\/j.yjmcc.2025.02.010_bb0900","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/FJC.0000000000000431","article-title":"Puerarin suppresses Na+-K+-ATPase-mediated systemic inflammation and CD36 expression and alleviates cardiac lipotoxicity in vitro and in vivo","volume":"68","author":"Qin","year":"2016","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"1","key":"10.1016\/j.yjmcc.2025.02.010_bb0905","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/FJC.0000000000000311","article-title":"Low-dose exogenous Ouabain alleviates cardiac lipotoxicity through suppressing expression of CD36","volume":"67","author":"Guo","year":"2016","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"12","key":"10.1016\/j.yjmcc.2025.02.010_bb0910","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1161\/CIRCRESAHA.119.314898","article-title":"Nuclear miR-320 mediates diabetes-induced cardiac dysfunction by activating transcription of fatty acid metabolic genes to cause lipotoxicity in the heart","volume":"125","author":"Li","year":"2019","journal-title":"Circ. Res."},{"issue":"12","key":"10.1016\/j.yjmcc.2025.02.010_bb0915","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1161\/CIRCRESAHA.119.316199","article-title":"Nuclear miR-320 controls lipotoxicity","volume":"125","author":"Tong","year":"2019","journal-title":"Circ. Res."},{"issue":"10","key":"10.1016\/j.yjmcc.2025.02.010_bb0920","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1172\/JCI30335","article-title":"Cardiomyocyte expression of PPARgamma leads to cardiac dysfunction in mice","volume":"117","author":"Son","year":"2007","journal-title":"J. Clin. Invest."},{"issue":"4","key":"10.1016\/j.yjmcc.2025.02.010_bb0925","doi-asserted-by":"crossref","first-page":"5193","DOI":"10.1002\/jcb.27795","article-title":"Microarray profiling analysis identifies the mechanism of miR-200b-3p\/mRNA-CD36 affecting diabetic cardiomyopathy via peroxisome proliferator activated receptor-\u03b3 signaling pathway","volume":"120","author":"Xu","year":"2019","journal-title":"J. Cell. Biochem."},{"issue":"28","key":"10.1016\/j.yjmcc.2025.02.010_bb0930","doi-asserted-by":"crossref","first-page":"23852","DOI":"10.1074\/jbc.M111.328708","article-title":"Perilipin 5, a lipid droplet-binding protein, protects heart from oxidative burden by sequestering fatty acid from excessive oxidation","volume":"287","author":"Kuramoto","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yjmcc.2025.02.010_bb0935","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/8690746","article-title":"Plin5\/p-Plin5 guards diabetic CMECs by regulating FFAs metabolism Bidirectionally","volume":"2019","author":"Du","year":"2019","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.yjmcc.2025.02.010_bb0940","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110306","article-title":"Docosahexaenoic acid protects against palmitate-induced mitochondrial dysfunction in diabetic cardiomyopathy","volume":"128","author":"Gui","year":"2020","journal-title":"Biomed. Pharmacother."},{"issue":"5","key":"10.1016\/j.yjmcc.2025.02.010_bb0945","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2024.167158","article-title":"Cholesterol 25-hydroxylase prevents type 2 diabetes mellitus induced cardiomyopathy by alleviating cardiac lipotoxicity","volume":"1870","author":"Zhang","year":"2024","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"key":"10.1016\/j.yjmcc.2025.02.010_bb0950","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.610835","article-title":"Turbina oblongata protects against oxidative cardiotoxicity by suppressing lipid Dysmetabolism and modulating Cardiometabolic activities linked to cardiac dysfunctions","volume":"12","author":"Erukainure","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.yjmcc.2025.02.010_bb0955","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2024.176609","article-title":"Ginsenoside Rb1 ameliorates lipotoxicity-induced myocardial injury in diabetes mellitus by regulating Mfn2","volume":"974","author":"Ji","year":"2024","journal-title":"Eur. J. Pharmacol."},{"issue":"12","key":"10.1016\/j.yjmcc.2025.02.010_bb0960","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1113\/jphysiol.2013.270538","article-title":"Impairments in mitochondrial palmitoyl-CoA respiratory kinetics that precede development of diabetic cardiomyopathy are prevented by resveratrol in ZDF rats","volume":"592","author":"Beaudoin","year":"2014","journal-title":"J. Physiol."},{"issue":"20","key":"10.1016\/j.yjmcc.2025.02.010_bb0965","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1161\/CIRCULATIONAHA.122.059631","article-title":"FGF21-Sirtuin 3 Axis confers the protective effects of exercise against diabetic cardiomyopathy by governing mitochondrial integrity","volume":"146","author":"Jin","year":"2022","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.yjmcc.2025.02.010_bb0970","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s00109-019-01861-2","article-title":"Exercise enhances cardiac function by improving mitochondrial dysfunction and maintaining energy homoeostasis in the development of diabetic cardiomyopathy","volume":"98","author":"Wang","year":"2020","journal-title":"J. Mol. Med. (Berl)"},{"issue":"63","key":"10.1016\/j.yjmcc.2025.02.010_bb0975","doi-asserted-by":"crossref","first-page":"106661","DOI":"10.18632\/oncotarget.21302","article-title":"Exacerbation of diabetic cardiac hypertrophy in OVE26 mice by angiotensin II is associated with JNK\/c-Jun\/miR-221-mediated autophagy inhibition","volume":"8","author":"Qian","year":"2017","journal-title":"Oncotarget"},{"issue":"8","key":"10.1016\/j.yjmcc.2025.02.010_bb0980","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2020.165806","article-title":"Mst1 knockdown alleviates cardiac lipotoxicity and inhibits the development of diabetic cardiomyopathy in db\/db mice","volume":"1866","author":"Xiong","year":"2020","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"issue":"2","key":"10.1016\/j.yjmcc.2025.02.010_bb0985","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1161\/CIRCRESAHA.116.304707","article-title":"MicroRNA-451 exacerbates lipotoxicity in cardiac myocytes and high-fat diet-induced cardiac hypertrophy in mice through suppression of the LKB1\/AMPK pathway","volume":"116","author":"Kuwabara","year":"2015","journal-title":"Circ. Res."},{"issue":"7","key":"10.1016\/j.yjmcc.2025.02.010_bb0990","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.3390\/antiox11071379","article-title":"Inhibition of GCN2 alleviates cardiomyopathy in type 2 diabetic mice via attenuating lipotoxicity and oxidative stress","volume":"11","author":"Yuan","year":"2022","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.yjmcc.2025.02.010_bb0995","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/3899356","article-title":"Recombinant human growth hormone inhibits lipotoxicity, oxidative stress, and apoptosis in a mouse model of diabetic cardiomyopathy","volume":"2021","author":"Pei","year":"2021","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"1","key":"10.1016\/j.yjmcc.2025.02.010_bb1000","first-page":"63","article-title":"Adipsin inhibits Irak2 mitochondrial translocation and improves fatty acid \u03b2-oxidation to alleviate diabetic cardiomyopathy","volume":"10","author":"Jiang","year":"2023","journal-title":"Mil. Med. Res."},{"key":"10.1016\/j.yjmcc.2025.02.010_bb1005","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.113948","article-title":"Upregulation of PKR pathway mediates glucolipotoxicity induced diabetic cardiomyopathy in vivo in wistar rats and in vitro in cultured cardiomyocytes","volume":"177","author":"Mangali","year":"2020","journal-title":"Biochem. Pharmacol."},{"issue":"3","key":"10.1016\/j.yjmcc.2025.02.010_bb1010","doi-asserted-by":"crossref","first-page":"3651","DOI":"10.1002\/jcb.27643","article-title":"Inhibition of protein kinase R protects against palmitic acid-induced inflammation, oxidative stress, and apoptosis through the JNK\/NF-kB\/NLRP3 pathway in cultured H9C2 cardiomyocytes","volume":"120","author":"Mangali","year":"2019","journal-title":"J. Cell. Biochem."},{"issue":"11","key":"10.1016\/j.yjmcc.2025.02.010_bb1015","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1016\/j.bbadis.2016.08.005","article-title":"Disruption of calpain reduces lipotoxicity-induced cardiac injury by preventing endoplasmic reticulum stress","volume":"1862","author":"Li","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"issue":"5","key":"10.1016\/j.yjmcc.2025.02.010_bb1020","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/aps.2010.31","article-title":"Improvement of mechanical heart function by trimetazidine in db\/db mice","volume":"31","author":"Li","year":"2010","journal-title":"Acta Pharmacol. Sin."},{"issue":"2","key":"10.1016\/j.yjmcc.2025.02.010_bb1025","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1161\/CIRCHEARTFAILURE.113.000672","article-title":"Angiotensin 1-7 ameliorates diabetic cardiomyopathy and diastolic dysfunction in db\/db mice by reducing lipotoxicity and inflammation","volume":"7","author":"Mori","year":"2014","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/j.yjmcc.2025.02.010_bb1030","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.112709","article-title":"The Chinese herbal medicine Fufang Zhenzhu Tiaozhi protects against diabetic cardiomyopathy by alleviating cardiac lipotoxicity-induced oxidative stress and NLRP3-dependent inflammasome activation","volume":"148","author":"Yan","year":"2022","journal-title":"Biomed. Pharmacother."},{"issue":"4","key":"10.1016\/j.yjmcc.2025.02.010_bb1035","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.023540","article-title":"Panax notoginseng Saponin protects against diabetic cardiomyopathy through lipid metabolism modulation","volume":"11","author":"Zhang","year":"2022","journal-title":"J. Am. Heart Assoc."},{"issue":"10","key":"10.1016\/j.yjmcc.2025.02.010_bb1040","article-title":"The critical role of Astragalus polysaccharides for the improvement of PPAR\u03b1 [ correction of PPRA\u03b1]-mediated lipotoxicity in diabetic cardiomyopathy","volume":"7","author":"Chen","year":"2012","journal-title":"PloS One"},{"issue":"2","key":"10.1016\/j.yjmcc.2025.02.010_bb1045","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jdiacomp.2014.11.007","article-title":"Astragalus polysaccharides repress myocardial lipotoxicity in a PPARalpha-dependent manner in vitro and in vivo in mice","volume":"29","author":"Chen","year":"2015","journal-title":"J. Diabetes Complications"},{"issue":"3","key":"10.1016\/j.yjmcc.2025.02.010_bb1050","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1007\/s11033-012-2325-1","article-title":"Therapy with Astragalus polysaccharides rescues lipotoxic cardiomyopathy in MHC-PPAR\u03b1 mice","volume":"40","author":"Chen","year":"2013","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.yjmcc.2025.02.010_bb1055","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.yjmcc.2014.09.022","article-title":"Sulforaphane prevents the development of cardiomyopathy in type 2 diabetic mice probably by reversing oxidative stress-induced inhibition of LKB1\/AMPK pathway","volume":"77","author":"Zhang","year":"2014","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"8","key":"10.1016\/j.yjmcc.2025.02.010_bb1060","doi-asserted-by":"crossref","first-page":"5771","DOI":"10.1111\/jcmm.14493","article-title":"L. 4-O-methylhonokiol protects against diabetic cardiomyopathy in type 2 diabetic mice by activation of AMPK-mediated cardiac lipid metabolism improvement","volume":"23","author":"Zheng","year":"2019","journal-title":"J. Cell. Mol. Med."},{"issue":"8","key":"10.1016\/j.yjmcc.2025.02.010_bb1065","doi-asserted-by":"crossref","first-page":"879","DOI":"10.7150\/ijbs.12101","article-title":"Magnolia bioactive constituent 4-O-methylhonokiol prevents the impairment of cardiac insulin signaling and the cardiac pathogenesis in high-fat diet-induced obese mice","volume":"11","author":"Zhang","year":"2015","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.yjmcc.2025.02.010_bb1070","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2021.108008","article-title":"The adiponectin signalling pathway - a therapeutic target for the cardiac complications of type 2 diabetes?","volume":"232","author":"Sharma","year":"2022","journal-title":"Pharmacol. Ther."},{"issue":"6","key":"10.1016\/j.yjmcc.2025.02.010_bb1075","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s10557-016-6694-x","article-title":"Can adiponectin help us to target diastolic dysfunction?","volume":"30","author":"Francisco","year":"2016","journal-title":"Cardiovasc. Drugs Ther."},{"issue":"7","key":"10.1016\/j.yjmcc.2025.02.010_bb1080","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1253\/circj.CJ-17-0458","article-title":"Role of Adipokines in cardiovascular disease","volume":"81","author":"Lau","year":"2017","journal-title":"Circ. J."},{"issue":"4","key":"10.1016\/j.yjmcc.2025.02.010_bb1085","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.3892\/etm.2014.1539","article-title":"Analysis of the association between adiponectin, adiponectin receptor 1 and diabetic cardiomyopathy","volume":"7","author":"Li","year":"2014","journal-title":"Exp. Ther. Med."},{"issue":"3","key":"10.1016\/j.yjmcc.2025.02.010_bb1090","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1210\/er.2005-0005","article-title":"Adiponectin and adiponectin receptors","volume":"26","author":"Kadowaki","year":"2005","journal-title":"Endocr. Rev."},{"issue":"3","key":"10.1016\/j.yjmcc.2025.02.010_bb1095","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.jsps.2014.11.011","article-title":"Adiponectin serum levels correlate with insulin resistance in type 2 diabetic patients","volume":"23","author":"Aleidi","year":"2015","journal-title":"Saudi Pharm. J."},{"key":"10.1016\/j.yjmcc.2025.02.010_bb1100","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/545068","article-title":"Total and high molecular weight adiponectin levels and prediction of cardiovascular risk in diabetic patients","volume":"2015","author":"Hor\u00e1kov\u00e1","year":"2015","journal-title":"Int. J. Endocrinol."},{"issue":"4","key":"10.1016\/j.yjmcc.2025.02.010_bb1105","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1080\/08037050410021397","article-title":"Associations among plasma adiponectin, hypertension, left ventricular diastolic function and left ventricular mass index","volume":"13","author":"Hong","year":"2004","journal-title":"Blood Press."},{"issue":"8","key":"10.1016\/j.yjmcc.2025.02.010_bb1110","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.2337\/db07-0185","article-title":"Selective downregulation of the high\u2013molecular weight form of adiponectin in hyperinsulinemia and in type 2 diabetes: differential regulation from nondiabetic subjects","volume":"56","author":"Basu","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.yjmcc.2025.02.010_bb1115","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/s41419-022-04726-8","article-title":"Adiponectin receptor agonist ameliorates cardiac lipotoxicity via enhancing ceramide metabolism in type 2 diabetic mice","author":"Kim","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.yjmcc.2025.02.010_bb1120","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/s41420-022-01046-w","article-title":"Mitochondrial damage and activation of the cytosolic DNA sensor cGAS\u2013STING pathway lead to cardiac pyroptosis and hypertrophy in diabetic cardiomyopathy mice","volume":"8","author":"Yan","year":"2022","journal-title":"Cell Death Discov."},{"issue":"1","key":"10.1016\/j.yjmcc.2025.02.010_bb1125","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s10565-021-09692-z","article-title":"Lipotoxicity-induced mtDNA release promotes diabetic cardiomyopathy by activating the cGAS-STING pathway in obesity-related diabetes","volume":"39","author":"Ma","year":"2023","journal-title":"Cell Biol. Toxicol."},{"key":"10.1016\/j.yjmcc.2025.02.010_bb1130","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.biopha.2021.111780","article-title":"Peroxiredomin-4 ameliorates lipotoxicity-induced oxidative stress and apoptosis in diabetic cardiomyopathy","volume":"141","author":"Zhang","year":"2021","journal-title":"Biomed. Pharmacother."}],"container-title":["Journal of Molecular and Cellular Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282825000379?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282825000379?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T08:53:34Z","timestamp":1777452814000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022282825000379"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":226,"alternative-id":["S0022282825000379"],"URL":"https:\/\/doi.org\/10.1016\/j.yjmcc.2025.02.010","relation":{},"ISSN":["0022-2828"],"issn-type":[{"value":"0022-2828","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lipotoxicity as a therapeutic target in the type 2 diabetic heart","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular and Cellular Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yjmcc.2025.02.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}